Navigation Links
Hydroxyurea Treatment For Children With Sickle Cell Disease

Sickle cell anemia is a genetic disorder characterized by distorted, sickle shaped red blood cells. The disease is associated with severe pain, fatigue, and organ damage to the kidneys, spleen, and liver. The sickle cell disease is // prevalent in African populations where the incidence is about 1 in 500.

Despite much clinical work, there is no good basic treatment for the disease. Pain can be relieved, and the frequency and duration of the crises can be lessened by rest, transfusions and antibiotics. It reduces quality of life, reproductive ability and life span.

A drug used for the treatment of sickle cell anemia in adults has now been shown to cause significant improvements in very young children with the disorder. The finding is an important one as these young patients are especially vulnerable to serious organ failure and even death at an early age.

In the new study, 21 children from two to four years old who had sickle cell anemia were given the drug hydroxyurea orally as a flavored liquid formula. A majority of the children took the drug for at least four years and more than half of the participants completed all six years of the study.

The treatment was well-tolerated in the patients, with only one child's dosage permanently reduced during the study due to adverse effects. Increasing and sustaining fetal hemoglobin production was accomplished by the drug in all study participants.

Patients treated with hydroxyurea also weighed more and were taller than untreated children with the disorder – their growth rates were even comparable to those of normal children. Another measure of success of the therapy was that the study patients had improved spleen function, an important finding as many children with sickle cell anemia lose spleen function by two years of age.

Participants also experienced significantly fewer incidents of acute chest syndrome, a potentially life-threatening disorder associated w
'"/>




Page: 1 2

Related medicine news :

1. Hydroxyurea derivatives kill colon cancer cells
2. Advances in Treatment of Cataracts
3. Recommendations for Treatment of Blood Pressue
4. Treatment for Menieres disease
5. Treatment for pre-menstrual syndrome is ineffective
6. Better Treatment for obesity
7. Gene Treatment for Heart Disease
8. More People Seeking Treatment for Depression
9. Focused Treatment For Childhood Cancer
10. Inadequate Drug Treatment For Youth
11. FDA Approves New surgery Treatment for Farsightedness

Post Your Comments:
(Date:12/1/2009)... 1 With employee benefit...f employers are providing self-service decision-ma...n, according to a new survey by Watson Wyatt, a le...ers who offer these tools believe they lead employ... According to the survey, 45 percent of companies ...
(Date:12/1/2009)...Dec. 1 On December 31, ...federal prisoners were HIV positive or had confirm... the Office of Justice Programs, U.S. Department o...timated 5,672 inmates in state and federal prisons...007, about 43 per 10,000 prison inmates were estim...
(Date:12/1/2009)... and South America, study finds , , TUES...f intensive care unit patients worldwide suffer in...e hospital, a new study finds. , Researchers an...) on 13,796 patients, aged 18 and older, in 1,265 ...f patients were classified as infected and 71 perc...
(Date:12/1/2009)...2009) Wistar Institute researchers and collaborat...rk University have identified immune system marker...ors in people at high risk for developing lung can... Cancer Research , a journal of the American Assoc... blood test to detect lung cancer in its earliest ...
(Date:12/1/2009)...GLE PARK, N.C., Dec. 1 Max Neeman ...expanded over the years serving the top most pharm...as originally set up in an area of 2000 sq. ft. ha...of the suite of services by Max Neeman, are recogn...ffering. ,, The pharmacy inventory management p...
Breaking Medicine News(10 mins):Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:Half of ICU Patients Suffer From Infections 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3
...elieve they eat a lot of meat because of the taste...the Journal of Consumer Research, the reason tha... to some people has more to do with values than ac...r Food Industries and Management, France) conducte...
...called a primary stumbling block , , THURS...care in the United States continues to elude more ...ore, since the first "scorecard" was done in 2006,...on. , These are some of the findings in the Common...
...vest Products,Inc. (OTC Bulletin Board: FRHV.OB) a...its long standing commitment to providing consumer...ings, through a new initiative to,build natural an...lieve that this new initiative is a natural and lo...
... Digital Documents, a,provider of turnkey, cost-ef...d HCAHPS Surveys, announced today the integration ... Health Systems, the largest,not-for-profit Protes...e expensive," commented Bruce,Genger, President of...
...January 2, 2009 -, LAVAL, QC, July 17 /PRNewswire...SS) today announced that the response that it subm...A) on July 2, 2008, including the,additional analy...cription Drug User Fee Act (PDUFA) is January 2, 2...
...IGNA, the health service company, launched its new...ents in the Wall Street Journal. Supported by Dore...gn will be the largest in CIGNA's history, an... Philadelphia, PA (PRWEB) July 1...
Other Medicine News:Health News:Good news for veggies 2Health News:U.S. Health Care Still Ill, Survey Finds 2Health News:U.S. Health Care Still Ill, Survey Finds 3Health News:Fresh Harvest Products, Inc. Announces New Brand Initiative 2Health News:Innovative HCAHPS Patient Satisfaction Survey Solution Generates Huge Cost-Savings Opportunity for Adventist Health Systems 2Health News:FDA accepts Labopharm's response for once-daily tramadol as complete Class 2 response 2Health News:CIGNA Launches National "It's Time to Feel Better" Advertising Campaign to Support Health Service Mission 2Health News:CIGNA Launches National "It's Time to Feel Better" Advertising Campaign to Support Health Service Mission 3
(Date:12/1/2009)...c. 1 CCS Medical, Inc. a leading d...day announced that it has received approval from t...Delaware (the "Court") for its bidding procedures ... of substantially all of its assets. ,, Pursuan...pproved bidding procedures for the sale of substan...
(Date:12/1/2009)...PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasda...on, today announced the honorees of the 2009 WebMD...lth Heroes honor Americans with extraordinary stor... an effort to help others achieve better health. ...prnh/20091201/NY18114 ) ,, "WebMD is honoring ...
(Date:12/1/2009)..., Dec. 1 nContact Surgical, Inc. (...ces for minimally-invasive treatment for heart con...bility clinical trial designed to evaluate the saf...er procedure, the convergent procedure, for the tr...ion (AF). This prospective, feasibility study wil...
Breaking Medicine Technology:CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Cobb Pediatric Therapy Services Joins Forces with Travis Consulting LLC to Offer Expanded Services Across the U S 57905 1Cobb Pediatric Therapy Services Joins Forces with Travis Consulting LLC to Offer Expanded Services Across the U S 57905 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 8Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 1Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 2Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 3
...d in Third Quarter -, SAN FRANCISCO, March 20 VI...y company focused on the development of,compounds ...nced today that,it has completed patient enrollmen...irst of three Phase 2 trials investigating VIA-229...1 is a potent small molecule drug that targets inf...
... not the Only Way We Suffer - Allerg...N.J. and WHITEHOUSE STATION, N.J., March 20, Indoo...ople in the United States.(1)(2) Yet, according to... survey, allergies are often,disregarded as a nuis...ect.,As a result, allergy sufferers continue to co...
Other Medicine Technology:VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 2VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 3VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 4VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 2New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 3New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 4New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 6New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 7
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: